Contact Us

Welcome to the Liverpool Cancer Trials Unit Website

The site includes information on the current trials that are being managed by the LCTU, current staff, information on Pancreatic cancer and useful links to other sites.

We hope that you enjoy looking round the site and if you have any queries or suggestions please don't hesitate to contact us using our email address:

For more information on cancer and the trials that are currently running within the UK please visit the Cancer Help Website

NB. All recruitment and site information on the LCTU website is updated in realtime from LCTU data management systems.

Latest News

ASCO POST - John P. Neoptolemos, MD, PhD, on Pancreatic Ductal Adenocarcinoma: Results of the ESPAC-4 Trial

John P. Neoptolemos, MD, PhD, of the University of Liverpool, discusses findings from this international phase III study of adjuvant combination chemotherapy: gemcitabine and capecitabine vs monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma (Abstract LBA4006).

Elisabeth Turner shortlisted for RCNi award

Research Nurse, Elisabeth Turner who works on the PANasta trial,  from the North West Coast Taskforce of the NIHR Clinical Research Network was shortlisted as a finalist in the Excellence in Cancer Research category of the 2016 RCNi Nurse Awards. The award, sponsored by Cancer Research UK recognises the role that clinical research nurses play in helping to deliver clinical trials. All finalists attended the award ceremony at the Westminster Park Plaza Hotel, Lisa Berry Editor in Cancer .....

Better Trials Make Better Surgeons Event

The North West Surgical Trials Centre is holding another of it's hugely successful surgical workshops in June and will include inspirational talks from experienced senior trialists, plus surgeons new to research. The afternoon will also provide the opportunity to discuss trial ideas, mechanics of setting-up studies etc. Please see the attached posters for further information and to book your free place.


ESPAC-4 at Best of ASCO Meeting

Abstract LBA4006: ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma. for presentation at the 2016 ASCO Annual Meeting.  This abstract has also been hand selected to be included in the Best of ASCO® program, which will be held this summer .....